These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 32148488)

  • 1. Analysis of the Effect of Nine Consecutive Years' Intensive Management and Number of Times Achieving the Target Control on Endpoint Events in T2DM Patients in Sanlitun Community Health Service Center in Beijing.
    Zhao CM; Cui XL; Wan G; Lu YZ; Niu YQ; Su CY; Cao S; Liang GX; Chen HW; Li J; Lu X; Deng ZY; Yu XH; Yang WX; Li JH; Fan H; Yang MX; Fu Y; Wei SP; He ZN; Zhang XL; Yuan SY
    Int J Endocrinol; 2020; 2020():3646342. PubMed ID: 32148488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24).
    Zhang XL; Yuan SY; Wan G; Yuan MX; Yang GR; Fu HJ; Zhu LX; Zhang JD; Li YL; Gao DY; Cui XL; Wang ZM; Xie RR; Chen YJ
    Sci Rep; 2021 Mar; 11(1):4839. PubMed ID: 33649485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22).
    Zhang XL; Wan G; Yuan MX; Yang GR; Fu HJ; Zhu LX; Xie RR; Lv YJ; Zhang JD; Li YL; Dai QF; Ji Y; Holman RR; Yuan SY;
    Diabetes Ther; 2020 Apr; 11(4):885-903. PubMed ID: 32086768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cardiovascular risk factor combined anti-platelet therapy and the risk of cerebrovascular events in patients with T2DM in an urban community over 96-months follow-up: The Beijing communities diabetes study 19.
    Zhang XL; Fu HJ; Yang GR; Wan G; Li D; Zhu LX; Xie RR; Lv YJ; Zhang JD; Li YL; Dai QF; Ji Y; Gao DY; Cui XL; Liu DY; Yuan SY; Yuan MX;
    Diabetes Res Clin Pract; 2018 Oct; 144():236-244. PubMed ID: 30218743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship between fasting blood glucose level and thromboembolism events in patients with non-valvular atrial fibrillation].
    Bo XW; Zuo S; Jiang C; He L; Zhao X; Li SN; Tang RB; Long DY; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):243-248. PubMed ID: 35340142
    [No Abstract]   [Full Text] [Related]  

  • 6. The Association between Metabolic Syndrome and Morbid Events in Type 2 Diabetes after a 7-Year Community Management: Beijing Community Diabetes Study 17.
    Yang GR; Yuan MX; Fu HJ; Wan G; Li D; Dye TD; Zhu LX; Xie RR; Lv YJ; Zhang JD; Du XP; Li YL; Ji Y; Li Y; Cui XL; Wang ZM; Cheng SY; Liu DY; Wang Q; Zhou L; Gao Y; Yuan SY
    J Diabetes Res; 2019; 2019():5237371. PubMed ID: 31281851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.
    Griffin SJ; Borch-Johnsen K; Davies MJ; Khunti K; Rutten GE; Sandbæk A; Sharp SJ; Simmons RK; van den Donk M; Wareham NJ; Lauritzen T
    Lancet; 2011 Jul; 378(9786):156-67. PubMed ID: 21705063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intelligent Internet-based information system optimises diabetes mellitus management in communities.
    Wei X; Wu H; Cui S; Ge C; Wang L; Jia H; Liang W
    Health Inf Manag; 2018 May; 47(2):70-76. PubMed ID: 28537206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
    Gæde P; Oellgaard J; Carstensen B; Rossing P; Lund-Andersen H; Parving HH; Pedersen O
    Diabetologia; 2016 Nov; 59(11):2298-2307. PubMed ID: 27531506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE.
    Poulter NR
    J Hypertens Suppl; 2009 May; 27(1):S3-8. PubMed ID: 19483505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stationary Treatment Compared with Individualized Chinese Medicine for Type 2 Diabetes Patients with Microvascular Complications: Study Protocol for a Randomized Controlled Trial.
    Huo J; Liu LS; Jian WY; Zeng JP; Duan JG; Lu XJ; Yin S
    Chin J Integr Med; 2018 Oct; 24(10):728-733. PubMed ID: 29915910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lindenfeld J; Zile MR; Desai AS; Bhatt K; Ducharme A; Horstmanshof D; Krim SR; Maisel A; Mehra MR; Paul S; Sears SF; Sauer AJ; Smart F; Zughaib M; Castaneda P; Kelly J; Johnson N; Sood P; Ginn G; Henderson J; Adamson PB; Costanzo MR
    Lancet; 2021 Sep; 398(10304):991-1001. PubMed ID: 34461042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
    Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.
    Beulens JW; Patel A; Vingerling JR; Cruickshank JK; Hughes AD; Stanton A; Lu J; McG Thom SA; Grobbee DE; Stolk RP; ;
    Diabetologia; 2009 Oct; 52(10):2027-36. PubMed ID: 19633827
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.